https://www.selleckchem.com/products/mli-2.html
k of death. Our investigators found that hospitalized patients with active cancer were more likely to die from coronavirus disease 2019 (COVID-19) than those with a history of cancer and those without any cancer history. Patients with hematologic cancers were the most likely among patients with cancer to die from COVID-19. Patients who received cancer therapy within 3 months before hospitalization did not have an increased risk of death. Our investigators found that hospitalized patients with active cancer were more likely to die from cor
Curtir
Comentario
Compartilhar
